Ingevity (NGVT) Liabilities and Shareholders Equity (2015 - 2026)

Ingevity (NGVT) has 12 years of Liabilities and Shareholders Equity data on file, last reported at $1.7 billion in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 19.74% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $7.0 billion, a 18.14% decrease from a year earlier, with the FY2025 full-year figure at $1.7 billion, down 18.37% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $1.7 billion, roughly flat from $1.7 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for NGVT reached as high as $2.8 billion in Q2 2023 and fell as low as $1.7 billion in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2022.
• Across the five-year window, Liabilities and Shareholders Equity climbed 19.54% in 2023 and declined 22.9% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $2.7 billion in 2022, then retreated by 4.14% to $2.6 billion in 2023, then retreated by 22.9% to $2.0 billion in 2024, then slipped by 18.37% to $1.7 billion in 2025, then decreased by 0.05% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.8 billion in Q3 2025.